VBI Vaccines (VBIV) Stock Chart & Stock Price History → Global crypto currency reset (41 major banks signed up) (From Stansberry Research) (Ad) Free VBIV Stock Alerts $0.63 -0.02 (-3.02%) (As of 05/17/2024 08:54 PM ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability VBI Vaccines Stock Price Performance5 Day Performance-1.08%1 Month Performance-0.58%3 Month Performance-2.51%6 Month Performance+2.44%Year-To-Date Performance+7.23%1 Year Performance-79.21% Receive VBIV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for VBI Vaccines and its competitors with MarketBeat's FREE daily newsletter Email Address Ad InvestorPlaceCrypto Pioneer Says: “The last crypto bull market has begun.”Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble.Click here if you’d like to learn more about these five cryptos… VBIV Stock Chart for Monday, May, 20, 2024 VBIV Chart by TradingView VBI Vaccines Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024$0.65$0.63-3.02%$0.65$0.62143,715 shs$18.07 million05/16/2024$0.66$0.65-1.13%$0.65$0.61136,425 shs$18.63 million05/15/2024$0.64$0.66+3.16%$0.67$0.63251,883 shs$18.84 million05/14/2024$0.63$0.64+0.70%$0.64$0.6255,033 shs$18.27 million05/13/2024$0.62$0.63+2.02%$0.64$0.60135,934 shs$18.14 million05/10/2024$0.60$0.62+2.77%$0.63$0.59121,604 shs$17.78 million Get the Latest News and Ratings for VBIV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for VBI Vaccines and its competitors with MarketBeat's FREE daily newsletter. 05/09/2024$0.60$0.60+0.55%$0.62$0.5835,748 shs$17.30 million05/08/2024$0.60$0.60-0.33%$0.62$0.5938,563 shs$17.21 million05/07/2024$0.60$0.60+0.35%$0.63$0.58109,052 shs$17.27 million05/06/2024$0.59$0.60+1.68%$0.60$0.56138,068 shs$17.21 million05/03/2024$0.58$0.59+1.27%$0.61$0.57165,340 shs$16.92 million05/02/2024$0.57$0.58+2.30%$0.59$0.5682,412 shs$16.71 million05/01/2024$0.57$0.57-0.26%$0.58$0.5671,760 shs$16.19 million04/30/2024$0.56$0.57+1.24%$0.57$0.54115,430 shs$16.23 million04/29/2024$0.57$0.56-1.74%$0.59$0.53483,754 shs$16.04 million04/26/2024$0.60$0.57-4.24%$0.60$0.56187,246 shs$16.32 million04/25/2024$0.59$0.60+1.59%$0.60$0.56123,634 shs$17.04 million04/24/2024$0.61$0.59-3.04%$0.61$0.58130,137 shs$16.78 million04/23/2024$0.60$0.61+0.91%$0.62$0.58112,934 shs$17.30 million04/22/2024$0.63$0.60-4.84%$0.66$0.58302,393 shs$17.14 million04/19/2024$0.63$0.63+0.64%$0.65$0.61163,515 shs$18.02 million04/18/2024$0.61$0.63+3.40%$0.64$0.58179,877 shs$14.92 million04/17/2024$0.62$0.61-1.77%$0.65$0.58373,465 shs$14.43 million04/16/2024$0.58$0.62+6.90%$0.64$0.56469,600 shs$14.69 million04/15/2024$0.58$0.58$0.58$0.55273,042 shs$13.74 million04/12/2024$0.60$0.58-3.33%$0.61$0.55505,812 shs$13.74 million04/11/2024$0.64$0.60-5.96%$0.63$0.55611,297 shs$14.21 million04/10/2024$0.66$0.64-3.33%$0.73$0.571.69 million shs$15.11 million04/09/2024$0.92$0.66-28.34%$1.35$0.656.74 million shs$15.64 million04/08/2024$0.71$0.92+29.72%$0.98$0.701.43 million shs$21.82 million04/05/2024$0.67$0.71+6.26%$0.72$0.65235,992 shs$16.82 million04/04/2024$0.75$0.67-11.18%$0.77$0.661.87 million shs$15.83 million04/03/2024$0.70$0.75+7.47%$0.77$0.662.67 million shs$17.82 million04/02/2024$0.62$0.70+13.25%$0.73$0.593.86 million shs$16.58 million04/01/2024$0.60$0.62+2.57%$0.63$0.60171,407 shs$14.64 million03/29/2024$0.60$0.60$0.61$0.59128,704 shs$14.28 million03/28/2024$0.58$0.60+3.90%$0.61$0.59125,291 shs$14.28 million03/27/2024$0.58$0.58$0.59$0.5690,814 shs$13.74 million03/26/2024$0.57$0.58+0.89%$0.59$0.5836,652 shs$13.74 million03/25/2024$0.58$0.57-0.05%$0.59$0.5634,132 shs$13.62 millionElon’s New Device is About to Shock the World (Ad)Using this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake.03/22/2024$0.57$0.58+1.81%$0.59$0.5648,163 shs$13.63 million03/21/2024$0.58$0.57-1.74%$0.60$0.5690,415 shs$13.39 million03/20/2024$0.56$0.58+2.29%$0.60$0.5872,746 shs$13.62 million03/19/2024$0.57$0.56-1.40%$0.59$0.5628,154 shs$13.32 million03/18/2024$0.56$0.57+1.68%$0.59$0.5751,553 shs$13.51 million03/15/2024$0.59$0.56-4.92%$0.60$0.5644,631 shs$13.28 million03/14/2024$0.59$0.59-0.05%$0.61$0.5781,668 shs$13.97 million03/13/2024$0.60$0.59-0.91%$0.63$0.5945,503 shs$13.98 million03/12/2024$0.60$0.60-0.77%$0.63$0.5985,255 shs$14.11 million03/11/2024$0.58$0.60+3.45%$0.64$0.58170,956 shs$14.21 million03/08/2024$0.58$0.58-0.84%$0.59$0.56111,948 shs$13.74 million03/07/2024$0.60$0.58-1.70%$0.60$0.5736,669 shs$13.86 million03/06/2024$0.58$0.60+2.23%$0.60$0.5842,500 shs$14.09 million03/05/2024$0.60$0.58-2.43%$0.60$0.57131,582 shs$13.79 million03/04/2024$0.59$0.60+1.10%$0.60$0.57108,678 shs$14.13 million03/01/2024$0.58$0.59+1.72%$0.60$0.5775,887 shs$13.98 million02/29/2024$0.57$0.58+2.64%$0.59$0.5692,190 shs$13.74 million02/28/2024$0.57$0.57+0.02%$0.59$0.5662,521 shs$13.39 million02/27/2024$0.58$0.57-3.10%$0.59$0.5668,248 shs$13.39 million02/26/2024$0.57$0.58+2.28%$0.60$0.5649,149 shs$13.81 million02/23/2024$0.57$0.57+0.90%$0.60$0.5721,063 shs$13.51 million02/22/2024$0.63$0.57-10.46%$0.65$0.55198,171 shs$13.39 million02/21/2024$0.63$0.63+0.14%$0.65$0.60179,712 shs$14.95 million02/20/2024$0.65$0.63-2.49%$0.65$0.60166,586 shs$14.93 million02/19/2024$0.65$0.65$0.70$0.60397,500 shs$15.31 million Related Companies: Galecto Stock Chart Aytu BioPharma Stock Chart Sol-Gel Technologies Stock Chart Indaptus Therapeutics Stock Chart GlycoMimetics Stock Chart Cocrystal Pharma Stock Chart Minerva Neurosciences Stock Chart Talphera Stock Chart KALA BIO Stock Chart NeuroBo Pharmaceuticals Stock Chart Receive VBIV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for VBI Vaccines and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VBIV) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaNext President (Not Trump. Not Biden.)The Freeport SocietyUrgent Nvidia WarningAltimetryElon’s New Device is About to Shock the WorldInvestorPlace"The Biggest Drug Ever" Is ComingBehind the MarketsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VBI Vaccines Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.